Search

Your search keyword '"Haagmans, Bart L."' showing total 1,194 results

Search Constraints

Start Over You searched for: Author "Haagmans, Bart L." Remove constraint Author: "Haagmans, Bart L."
1,194 results on '"Haagmans, Bart L."'

Search Results

1. An updated framework for SARS-CoV-2 variants reflects the unpredictability of viral evolution

5. Original COVID-19 priming regimen impacts the immunogenicity of bivalent BA.1 and BA.5 boosters

6. Filamentous fungus-produced human monoclonal antibody provides protection against SARS-CoV-2 in hamster and non-human primate models

7. Dissecting humoral immune responses to an MVA-vectored MERS-CoV vaccine in humans using a systems serology approach

9. Defining the risk of SARS-CoV-2 variants on immune protection

10. Extended Viral Shedding of MERS-CoV Clade B Virus in Llamas Compared with African Clade C Strain

11. Fangchinoline inhibits SARS-CoV-2 and MERS-CoV entry

13. The impact of BNT162b2 mRNA vaccine on adaptive and innate immune responses

14. Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals

15. An early warning system for emerging SARS-CoV-2 variants

16. Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination

17. Persistence of MERS-CoV-spike-specific B cells and antibodies after late third immunization with the MVA-MERS-S vaccine

21. Increased neutralization and IgG epitope identification after MVA-MERS-S booster vaccination against Middle East respiratory syndrome

22. Detection of Double-Stranded RNA Intermediates During SARS-CoV-2 Infections of Syrian Golden Hamsters with Monoclonal Antibodies and Its Implications for Histopathological Evaluation of In Vivo Studies.

23. Interferon-α2 Auto-antibodies in Convalescent Plasma Therapy for COVID-19

24. Methods for fighting emerging pathogens

27. Virus genomes reveal factors that spread and sustained the Ebola epidemic

28. Filamentous fungus-produced human monoclonal antibody provides protection against SARS-CoV-2 in hamster and non-human primate models

29. Human conjunctiva organoids to study ocular surface homeostasis and disease

30. Original COVID-19 priming regimen impacts the immunogenicity of bivalent BA.1 and BA.5 boosters

31. Advancing COVID-19 diagnostics:rapid detection of intact SARS-CoV-2 using viability RT-PCR assay

32. Filamentous fungus-produced human monoclonal antibody provides protection against SARS-CoV-2 in hamster and non-human primate models

33. Human conjunctiva organoids to study ocular surface homeostasis and disease

34. Human metapneumovirus infection of organoid-derived human bronchial epithelium represents cell tropism and cytopathology as observed in in vivo models

35. Comparative Pathogenesis of Severe Acute Respiratory Syndrome Coronaviruses

36. Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial

40. Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19)

42. A conserved immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies

43. Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infection

44. Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease Patients

45. Serologic Detection of Middle East Respiratory Syndrome Coronavirus Functional Antibodies

46. Animal models for COVID-19

49. An organoid‐derived bronchioalveolar model for SARS‐CoV‐2 infection of human alveolar type II‐like cells

50. Sensitive and Specific Detection of Low-Level Antibody Responses in Mild Middle East Respiratory Syndrome Coronavirus Infections

Catalog

Books, media, physical & digital resources